Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study

[1]  L. Heding.  Radioimmunological determination of human C-peptide in serum , 1975, Diabetologia.

[2]  J. Dent,et al.  Hyperglycaemia slows gastric emptying in Type 1 (insulin-dependent) diabetes mellitus , 1990, Diabetologia.

[3]  R. Turner,et al.  Sulphonylurea therapy doubles B-cell response to glucose in Type 2 diabetic patients , 1985, Diabetologia.

[4]  A. Melander,et al.  The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia , 2004, European Journal of Clinical Pharmacology.

[5]  L. Groop,et al.  Dose-Dependent Effects of Glyburide on Insulin Secretion and Glucose Uptake in Humans , 1991, Diabetes Care.

[6]  J. Gerich,et al.  Dose-response characteristics for glucose-stimulated insulin release in man and assessment of influence of glucose on arginine-stimulated insulin release. , 1990, Metabolism: clinical and experimental.

[7]  K. Polonsky,et al.  Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus. , 1989, The Journal of clinical endocrinology and metabolism.

[8]  R. Turner,et al.  Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. , 1989, Metabolism: clinical and experimental.

[9]  L. Groop,et al.  HYPERGLYCAEMIA AND ABSORPTION OF SULPHONYLUREA DRUGS , 1989, The Lancet.

[10]  R. Turner,et al.  The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates. , 1988, Metabolism: clinical and experimental.

[11]  L. Groop,et al.  Different Effects of Glyburide and Glipizide on Insulin Secretion and Hepatic Glucose Production in Normal and NIDDM Subjects , 1987, Diabetes.

[12]  L. Groop,et al.  Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment. , 1987, Diabetes care.

[13]  K. Alberti,et al.  Effects of short-term hyperglycemia on insulin secretion in normal humans. , 1986, The American journal of physiology.

[14]  D. Porte,et al.  Clinical aspects of islet B-cell function in non-insulin-dependent diabetes mellitus. , 1986, Diabetes/metabolism reviews.

[15]  R. DeFronzo,et al.  Mechanism of Improvement in Glucose Metabolism After Chronic Glyburide Therapy , 1984, Diabetes.

[16]  R. DeFronzo,et al.  Mechanism of improvement in glucose metabolism after chronic glyburide therapy. , 1984, Diabetes.

[17]  J. Halter,et al.  Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose. , 1982, The Journal of clinical endocrinology and metabolism.

[18]  J. Halter,et al.  Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus. , 1981, The Journal of clinical endocrinology and metabolism.

[19]  H. Joost,et al.  On the relation of glucose and insulin secretion in the fasting state. , 1980, Metabolism: clinical and experimental.

[20]  A. Melander,et al.  High-performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum. , 1979, Journal of chromatography.

[21]  J. Halter,et al.  Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for imparied glucose potentiation. , 1979, The Journal of clinical endocrinology and metabolism.

[22]  E. Tsalikian,et al.  The Effect of Chronic Oral Antidiabetic Therapy on Insulin and Glucagon Responses to a Meal , 1977, Diabetes.

[23]  D. Porte,et al.  The effect of rate and dose of glucose infusion on the acute insulin response in man. , 1976, The Journal of clinical endocrinology and metabolism.

[24]  D. Porte,et al.  Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. , 1976, The Journal of clinical endocrinology and metabolism.

[25]  W. Duckworth,et al.  Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels. , 1972, The Journal of clinical endocrinology and metabolism.

[26]  C. J. Goodner,et al.  The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy. , 1968, Annals of internal medicine.

[27]  G. Reaven,et al.  Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus , 1967, Diabetes.

[28]  P. J. Randle,et al.  Immunoassay of insulin with insulin-antibody precipitate. , 1963, The Biochemical journal.

[29]  Auguste Loubatières.  THE HYPOGLYCEMIC SULFONAMIDES: HISTORY AND DEVELOPMENT OF THE PROBLEM FROM 1942 TO 1955 , 1957, Annals of the New York Academy of Sciences.